Trial Profile

A single dose, cross-over pharmacokinetic study comparing oral formulations of BNC210 in healthy male volunteers

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BNC 210 (Primary)
Indications Agitation; Anxiety disorders; Post-traumatic stress disorders
Focus Pharmacokinetics
Sponsors Bionomics

Most Recent Events

05 Dec 2018 Status changed from Active not recruiting to completed.
08 Aug 2018 Planned End Date changed from 2 Aug 2018 to 9 Aug 2018.
19 Jul 2018 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com